Solesence Inc. Common Stock (SLSN)

FairStock Score: 29/100 — RISKY

Key Financials

Strengths

• Solid return on equity of 11.0% above cost of capital

Concerns

• Trades significantly above Graham Number ($0) with negative 229% margin of safety—limited downside protection
• Revenue declining at 0.7% year-over-year signals potential demand weakness or market share loss
• Altman Z-Score of -0.7 places it in the financial distress zone—elevated bankruptcy risk
• No meaningful dividend despite modest growth—total return depends entirely on multiple expansion

AI Analysis

Solesence Inc. Common Stock is a micro-cap consumer defensive company valued at $79 million. Revenue stands at $62 million. From a quality standpoint, Solesence shows solid Piotroski F-Score of 6/9 and distressed Altman Z-Score of -0.7 warrants caution. On valuation, the stock is commanding a steep 55.5x multiple, with trades far above its Graham Number ($0) with no margin of safety. Growth dynamics show revenue growing at -0.7% and profit growth of 129.2%. Our composite FairStock Score of 29/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

At 56x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer